Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

IntroductionClinical remission as a multicomponent treatment goal in severe asthma is being explored in clinical practice. This post hoc analysis used data from the REDES study to assess the proportion of patients with severe eosinophilic asthma achieving our multicomponent definitions of clinical r...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
Ձևաչափ:	Հոդված
Լեզու:	English
Հրապարակվել է:	Frontiers Media S.A. 2023-04-01
Շարք:	Frontiers in Immunology
Խորագրեր:	severe asthma remission clinical outcomes real-world eosinophil biology mepolizumab
Առցանց հասանելիություն:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150162/full

Նմանատիպ նյութեր

A Case of Eosinophilic Gastroenteritis Remission Achieved Steroid-Free With Mepolizumab
‌: Yuki Hirata, և այլն
Հրապարակվել է: (2022-01-01)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
‌: Masanobu Ueno, և այլն
Հրապարակվել է: (2022-06-01)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
‌: Mkorombindo T, և այլն
Հրապարակվել է: (2019-08-01)

Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab
‌: Diego Bagnasco, և այլն
Հրապարակվել է: (2024-04-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
‌: Steven W. Yancey, և այլն
Հրապարակվել է: (2019-09-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
‌: Haldar P
Հրապարակվել է: (2017-06-01)

Mepolizumab-responsive recurrent eosinophilic eruption without peripheral eosinophilia
‌: Nina B. Curkovic, MD, և այլն
Հրապարակվել է: (2024-11-01)

The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?
‌: Masamitsu Hamakawa, և այլն
Հրապարակվել է: (2024-01-01)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
‌: Masanobu Ueno, և այլն
Հրապարակվել է: (2021-03-01)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
‌: Ryota Otoshi, և այլն
Հրապարակվել է: (2020-03-01)

Clinical efficacy of mepolizumab in the treatment of severe eosinophilic asthma in children
‌: V. N. Drozdov, և այլն
Հրապարակվել է: (2020-11-01)

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
‌: Giuseppe A. Ramirez, և այլն
Հրապարակվել է: (2022-12-01)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
‌: Pelaia C, և այլն
Հրապարակվել է: (2017-10-01)

May mepolizumab used in asthma correct subfertility?
‌: Guzin Ozden, և այլն
Հրապարակվել է: (2021-01-01)

Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab
‌: Nobuhiro Matsumoto, և այլն
Հրապարակվել է: (2019-10-01)

Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
‌: Venkata Nagarjuna Maturu, և այլն
Հրապարակվել է: (2021-08-01)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
‌: Takanori Numata, և այլն
Հրապարակվել է: (2019-10-01)

Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma
‌: Jolita Palacionyte, և այլն
Հրապարակվել է: (2024-06-01)

Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab
‌: Alistair Cook, և այլն
Հրապարակվել է: (2021-05-01)

Predictors of the enhanced response to mepolizumab treatment for severe eosinophilic asthma: A retrospective, long-term study
‌: Takanori Numata, և այլն
Հրապարակվել է: (2020-01-01)

Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
‌: Kenneth R. Chapman, և այլն
Հրապարակվել է: (2024-02-01)

Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
‌: I. J. Pouliquen, և այլն
Հրապարակվել է: (2017-11-01)

Mepolizumab para el tratamiento de asma grave eosinofílica
‌: Armando Partida-Gaytán, և այլն
Հրապարակվել է: (2021-01-01)

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report
‌: M. Sabbe, և այլն
Հրապարակվել է: (2024-01-01)

Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan
‌: Takashi Yamane, և այլն
Հրապարակվել է: (2023-06-01)

Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options
‌: Magdalena Żychowska, և այլն
Հրապարակվել է: (2020-06-01)

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
‌: Moetemri Zied, և այլն
Հրապարակվել է: (2023-09-01)

Real-world outcomes of mepolizumab treatment in severe eosinophilic asthma patients - retrospective cohort study in Slovakia
‌: Milos Jesenak, և այլն
Հրապարակվել է: (2023-09-01)

Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone
‌: Madeleine Lachance, MD, և այլն
Հրապարակվել է: (2022-04-01)

Combination effect of Mepolizumab and Endobronchial Watanabe Spigot (EWS) in drug‐induced eosinophilic pneumonia complicated by refractory pneumothorax
‌: Nana Ayame, և այլն
Հրապարակվել է: (2024-09-01)

Switching from omalizumab to mepolizumab therapy improved extra‐pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis
‌: Yu‐Hsuan Chen, և այլն
Հրապարակվել է: (2022-01-01)

Role of mepolizumab in severe allergic asthma with vocal cord polyp
‌: Azmat Karim, և այլն
Հրապարակվել է: (2022-01-01)

Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
‌: Carlo Lombardi, և այլն
Հրապարակվել է: (2024-07-01)

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
‌: Peter G. Gibson, և այլն
Հրապարակվել է: (2021-06-01)

Severe asthma remaining well‐controlled after mepolizumab discontinuation: A case report and literature review
‌: Takahiro Matsuyama, և այլն
Հրապարակվել է: (2023-06-01)

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
‌: Nami Masumoto, և այլն
Հրապարակվել է: (2023-05-01)

Severe eosinophilic bronchial asthma: new therapeutic options
‌: N. M. Nenasheva
Հրապարակվել է: (2018-10-01)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
‌: Marco Caminati, և այլն
Հրապարակվել է: (2023-09-01)

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response
‌: Mark Lai, և այլն
Հրապարակվել է: (2023-03-01)

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
‌: Manuel David Gil-Sierra, և այլն
Հրապարակվել է: (2019-11-01)